Daavlin NeoLux 3 Series - UVA Clearing Phase Protocols (Skin Types IV - VI)

MNL-00008 [5] Proprietary and Confidential Page 41 of 55
UVA, Skin Type III, 3/week
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
PRIMARY DOSE
(JOULES)
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
11.0
11.5
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
SECONDARY
DOSE (JOULES)
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
11.0
11.5
12.0
12.0
12.0
12.0
12.0
UVA, Skin Type III, 2/week
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
PRIMARY DOSE
(JOULES)
3.5
5.0
6.5
8.0
9.5
11.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
SECONDARY
DOSE (JOULES)
2.0
3.0
4.0
5.0
5.5
6.0
6.50
7.0
7.5
8.0
8.5
9.0
9.5
10.0
10.5
11.0
11.5
12.0
12.0
12.0
12.0
12.0
12.0
12.0
12.0
23.2 UVA Clearing Phase Protocols (Skin Types IV - VI)
Maximum Number of Treatments = 25
UVA, Skin Type IV, 11011
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
PRIMARY DOSE
(JOULES)
3.5
3.5
4.5
4.5
5.5
5.5
6.5
6.5
7.5
7.5
8.5
8.5
9.5
9.5
10.5
10.5
11.5
11.5
12.5
12.5
13.5
13.5
14.0
14.0
14.0
SECONDARY
DOSE (JOULES)
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
11.0
12.0
13.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
UVA, Skin Type IV, 3/week
TREATMENT #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
PRIMARY DOSE
(JOULES)
4.5
5.5
6.5
7.5
8.5
9.5
10.5
11.5
12.5
13.5
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
SECONDARY
DOSE (JOULES)
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
11.0
12.0
13.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0
14.0